Profile data is unavailable for this security.
About the company
Aroa Biosurgery Limited is a soft-tissue regeneration company. It develops, manufactures, sells, and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction. Its products are developed from the AROA extracellular matrix (ECM) technology platform, an extracellular matrix biomaterial derived from the ovine forestomach. AROA ECM is an ECM biomaterial containing a rich and complex mix of biological molecules that serve as the building blocks for a range of soft tissue repair products. Its products include Endoform, Myriad Matrix, Myriad Morcells, Myriad Morcells Fine, Symphony, and Reinforced Bioscaffolds. Endoform products support all phases of wound healing and are appropriate for use early in wound management to restore protease balance and advance healing to the proliferative phase. Myriad Matrix is an engineered ECM designed for soft tissue repair, reinforcement, and complex wounds.
- Revenue in AUD (TTM)77.16m
- Net income in AUD-1.55m
- Incorporated2007
- Employees261.00
- LocationAroa Biosurgery Ltd64 Richard Pearse Drive, MangereAUCKLAND 2022New ZealandNZL
- Phone+64 98693035
- Websitehttps://aroa.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Austco Healthcare Ltd | 81.41m | 5.93m | 134.91m | 174.00 | 22.49 | 2.53 | 15.33 | 1.66 | 0.016 | 0.016 | 0.2197 | 0.1421 | 1.02 | 3.91 | 4.67 | -- | 7.43 | 9.35 | 10.83 | 13.33 | 52.05 | 53.07 | 7.29 | 8.39 | 1.28 | -- | 0.1233 | -- | 39.98 | 19.76 | -16.15 | 18.83 | 25.65 | -- |
| Epiminder Ltd | -100.00bn | -100.00bn | 138.40m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -93.22 | -- | -99.64 | -- | -- | -- |
| Somnomed Ltd | 111.52m | -3.46m | 151.82m | 300.00 | -- | 3.24 | 66.29 | 1.36 | -0.0163 | -0.0163 | 0.5262 | 0.2147 | 1.48 | 6.53 | 7.25 | -- | -4.58 | -9.15 | -6.76 | -13.46 | 59.86 | 60.62 | -3.10 | -6.89 | 1.25 | -0.6067 | 0.1475 | -- | 21.63 | 14.24 | 71.77 | -- | 12.72 | -- |
| EMvision Medical Devices Ltd | 5.63m | -9.81m | 167.29m | -- | -- | 16.58 | -- | 29.72 | -0.1148 | -0.1148 | 0.0659 | 0.1086 | 0.2847 | -- | 694.01 | -- | -49.59 | -47.15 | -58.91 | -58.42 | -- | -- | -174.21 | -105.97 | -- | -93.34 | 0.2758 | -- | -51.31 | 41.83 | -259.23 | -- | -- | -- |
| Lumos Diagnostics Holdings Ltd | 17.49m | -10.13m | 218.13m | -- | -- | 23.71 | -- | 12.47 | -0.0147 | -0.0147 | 0.0257 | 0.0116 | 0.5205 | 7.04 | 4.91 | -- | -30.15 | -40.19 | -54.60 | -61.16 | 62.95 | 52.57 | -57.93 | -132.46 | 0.6816 | -10.69 | 0.5315 | -- | 11.40 | 17.12 | 16.40 | -- | -61.58 | -- |
| Aroa Biosurgery Ltd | 77.16m | -1.55m | 234.92m | 261.00 | -- | 2.98 | 139.65 | 3.04 | -0.0045 | -0.0045 | 0.2236 | 0.2285 | 0.8432 | 1.56 | 3.08 | -- | -1.70 | -8.53 | -1.85 | -9.75 | 85.07 | 82.71 | -2.01 | -15.20 | 5.74 | 0.3142 | 0.0706 | -- | 22.63 | 27.56 | 64.12 | -- | 14.62 | -- |
| Orthocell Ltd | 8.85m | -8.57m | 271.31m | -- | -- | 16.70 | -- | 30.65 | -0.0375 | -0.0375 | 0.0397 | 0.0599 | 0.2862 | 2.31 | 9.20 | -- | -27.70 | -28.14 | -34.17 | -33.47 | 68.98 | 71.87 | -96.78 | -167.82 | 4.78 | -- | 0.0381 | -- | 36.41 | 61.65 | -19.30 | -- | 45.43 | -- |
| Saluda Medical Inc | -100.00bn | -100.00bn | 297.39m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 36.13 | -- | -52.62 | -- | -- | -- |
| EchoIQ Ltd | 101.41k | -13.26m | 310.55m | -- | -- | 13.47 | -- | 3,062.31 | -0.0226 | -0.0226 | 0.0002 | 0.0353 | 0.0064 | -- | 0.6446 | -- | -83.87 | -68.78 | -89.84 | -81.95 | -- | -- | -13,078.12 | -3,892.98 | -- | -- | 0.00 | -- | 127.89 | -31.65 | -145.19 | -- | -16.56 | -- |
| Paragon Care Ltd | 3.62bn | 20.57m | 331.06m | 0.00 | 16.10 | 1.00 | 6.57 | 0.0915 | 0.0124 | 0.0124 | 2.18 | 0.1993 | 3.02 | 11.90 | 10.33 | -- | 1.72 | 1.79 | 4.47 | 4.07 | 9.04 | 8.90 | 0.5688 | 0.6081 | 0.6155 | 1.77 | 0.4699 | -- | 21.72 | 73.23 | 151.52 | -- | 18.34 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Harbour Asset Management Ltd.as of 23 Aug 2024 | 30.34m | 8.79% |
| Acorn Capital Ltd.as of 09 Oct 2025 | 26.19m | 7.59% |
| Australian Ethical Investments Ltd. (Investment Management)as of 16 Jun 2025 | 17.29m | 5.01% |
| Mirrabooka Investments Ltd. (Investment Management)as of 16 Jun 2025 | 11.43m | 3.31% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 5.33m | 1.55% |
| DFA Australia Ltd.as of 31 Dec 2025 | 1.25m | 0.36% |
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 297.38k | 0.09% |
| FCA Corp.as of 31 Dec 2025 | 145.00k | 0.04% |
| Betashares Capital NZ Ltd.as of 30 Jan 2026 | 63.97k | 0.02% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 52.71k | 0.02% |
